We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Trial of Botulinum Toxin for Isolated or Essential Head Tremor”. In the second half, we discuss how as semaglutide, also known by brand names Ozempic or Wegovy, continues to make headlines, a new drug called Zepbound is entering the weight loss sphere. Next, we discuss organ transplants and a new antibiotics developed for the treament of gonorrhea, Zoliflodacin. Last but not least, we discuss why March of Dimes, a maternal and infant health organization, issued a D+ to the USA for the 2nd year in a row for its relatively high rate of preterm births.
We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: https://bit.ly/2zZnJt9
